FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3011894734> ?p ?o ?g. }

• W3011894734 endingPage "572" @default.
• W3011894734 startingPage "566" @default.
• W3011894734 abstract "To investigate whether tumour necrosis factor alpha inhibitors (TNFis) are associated with an increased risk of neuroinflammatory diseases among patients with arthritic diseases.Cohorts of patients with rheumatoid arthritis (RA, n=25 796), psoriatic arthritis (PsA, n=8586) and ankylosing spondylitis (AS, n=9527) who initiated a TNFi treatment year 2000-2017 were identified from nationwide clinical rheumatology registers in Sweden and Denmark. Information on demyelinating disease and inflammatory neuropathy diagnoses was retrieved from prospective linkage to National Patients Register. A Cox proportional hazard model was used to estimate HRs and 95% CI comparing TNFi exposed and non-exposed, by disease and country.Among 111 455 patients with RA, we identified 270 (Sweden) and 51 (Denmark) events (all types of neuroinflammatory diseases combined), corresponding to crude incidence rates (per 1000 person-years) of 0.37 (Sweden) and 0.39 (Denmark) in TNFi-treated patients vs 0.39 (Sweden) and 0.28 (Denmark) in unexposed patients, and an age-sex-calendar-period-adjusted HR (95% CI) of 0.97 (0.72 to 1.33) (Sweden) and 1.45 (0.74 to 2.81) (Denmark) in TNFi exposed compared with non-exposed patients. For a total of 64 065 AS/PsA patients, the corresponding numbers were: 196 and 32 events, crude incidence rates of 0.59 and 0.87 in TNFi-treated patients vs 0.40 and 0.19 in unexposed patients, and HRs of 1.50 (1.07 to 2.11) and 3.41 (1.30 to 8.96), for Sweden and Denmark, respectively. For multiple sclerosis, the patterns of HRs were similar.Use of TNFi in AS/PsA, but not in RA, was associated with increased risk of incident neuroinflammatory disease, though the absolute risk was below one in 1000 patients/year." @default.
• W3011894734 created "2020-03-23" @default.
• W3011894734 creator A5003414068 @default.
• W3011894734 creator A5004151210 @default.
• W3011894734 creator A5014778751 @default.
• W3011894734 creator A5021975602 @default.
• W3011894734 creator A5042282070 @default.
• W3011894734 creator A5052693500 @default.
• W3011894734 creator A5054559944 @default.
• W3011894734 creator A5061721413 @default.
• W3011894734 creator A5076176735 @default.
• W3011894734 creator A5080616680 @default.
• W3011894734 creator A5083260909 @default.
• W3011894734 creator A5085365494 @default.
• W3011894734 date "2020-03-11" @default.
• W3011894734 modified "2023-10-09" @default.
• W3011894734 title "Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden" @default.
• W3011894734 cites W1515014891 @default.
• W3011894734 cites W1535604109 @default.
• W3011894734 cites W1968219642 @default.
• W3011894734 cites W1976310771 @default.
• W3011894734 cites W1977233832 @default.
• W3011894734 cites W1978670003 @default.
• W3011894734 cites W1997192647 @default.
• W3011894734 cites W2000665475 @default.
• W3011894734 cites W2004134188 @default.
• W3011894734 cites W2034948055 @default.
• W3011894734 cites W2050913859 @default.
• W3011894734 cites W2056805772 @default.
• W3011894734 cites W2056941295 @default.
• W3011894734 cites W2057062081 @default.
• W3011894734 cites W2064959326 @default.
• W3011894734 cites W2066896272 @default.
• W3011894734 cites W2069606030 @default.
• W3011894734 cites W2076651424 @default.
• W3011894734 cites W2077753096 @default.
• W3011894734 cites W2097145477 @default.
• W3011894734 cites W2110511698 @default.
• W3011894734 cites W2117451838 @default.
• W3011894734 cites W2132843336 @default.
• W3011894734 cites W2137398742 @default.
• W3011894734 cites W2166018731 @default.
• W3011894734 cites W2168021466 @default.
• W3011894734 cites W2219591537 @default.
• W3011894734 cites W2236748756 @default.
• W3011894734 cites W2480036115 @default.
• W3011894734 cites W2543221315 @default.
• W3011894734 cites W2568474721 @default.
• W3011894734 cites W2602416590 @default.
• W3011894734 cites W2769552088 @default.
• W3011894734 cites W2914237707 @default.
• W3011894734 cites W2894328281 @default.
• W3011894734 doi "https://doi.org/10.1136/annrheumdis-2019-216693" @default.
• W3011894734 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32161058" @default.
• W3011894734 hasPublicationYear "2020" @default.
• W3011894734 type Work @default.
• W3011894734 sameAs 3011894734 @default.
• W3011894734 citedByCount "31" @default.
• W3011894734 countsByYear W30118947342020 @default.
• W3011894734 countsByYear W30118947342021 @default.
• W3011894734 countsByYear W30118947342022 @default.
• W3011894734 countsByYear W30118947342023 @default.
• W3011894734 crossrefType "journal-article" @default.
• W3011894734 hasAuthorship W3011894734A5003414068 @default.
• W3011894734 hasAuthorship W3011894734A5004151210 @default.
• W3011894734 hasAuthorship W3011894734A5014778751 @default.
• W3011894734 hasAuthorship W3011894734A5021975602 @default.
• W3011894734 hasAuthorship W3011894734A5042282070 @default.
• W3011894734 hasAuthorship W3011894734A5052693500 @default.
• W3011894734 hasAuthorship W3011894734A5054559944 @default.
• W3011894734 hasAuthorship W3011894734A5061721413 @default.
• W3011894734 hasAuthorship W3011894734A5076176735 @default.
• W3011894734 hasAuthorship W3011894734A5080616680 @default.
• W3011894734 hasAuthorship W3011894734A5083260909 @default.
• W3011894734 hasAuthorship W3011894734A5085365494 @default.
• W3011894734 hasConcept C120665830 @default.
• W3011894734 hasConcept C121332964 @default.
• W3011894734 hasConcept C126322002 @default.
• W3011894734 hasConcept C188816634 @default.
• W3011894734 hasConcept C198451711 @default.
• W3011894734 hasConcept C207103383 @default.
• W3011894734 hasConcept C2776260265 @default.
• W3011894734 hasConcept C2777077863 @default.
• W3011894734 hasConcept C2777226972 @default.
• W3011894734 hasConcept C2777402515 @default.
• W3011894734 hasConcept C2777575956 @default.
• W3011894734 hasConcept C2908647359 @default.
• W3011894734 hasConcept C44249647 @default.
• W3011894734 hasConcept C50382708 @default.
• W3011894734 hasConcept C61511704 @default.
• W3011894734 hasConcept C71924100 @default.
• W3011894734 hasConcept C72563966 @default.
• W3011894734 hasConcept C99454951 @default.
• W3011894734 hasConceptScore W3011894734C120665830 @default.
• W3011894734 hasConceptScore W3011894734C121332964 @default.
• W3011894734 hasConceptScore W3011894734C126322002 @default.
• W3011894734 hasConceptScore W3011894734C188816634 @default.
• W3011894734 hasConceptScore W3011894734C198451711 @default.

• next